Richard A. Paulson

Director, President and CEO · 1 filing · Latest: May 13, 2026

Karyopharm Therapeutics Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KPTI	Richard A. Paulson	Director, President and CEO	May 14, 2026	Sale	$9.50	2,203	$20.9K	269,747	May 15 4:03 PM
KPTI	Richard A. Paulson	Director, President and CEO	May 13, 2026	Grant/Award	$0.00	4,920	—	271,950	May 15 4:03 PM